Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announce review of their January 2016 ...

Dianthus Therapeutics targets severe autoimmune diseases with DNTH103. Read more on DNTH's promise amid competitive ...

Novavax’s protein-based vaccine is only available under a pandemic-era emergency-use authorization, and formal approval from ...

Sinch AB (publ), which is pioneering the way the world communicates through its Customer Communications Cloud, has today published its Annual Report for 2024. The report is available for download at ...

Swiss oncology firm Veraxa Biotech is set to go public in the US through a merger with Voyager Acquisition Corp, a healthcare ...

Arbutus Biopharma Corporation ("Arbutus" or the "Company"), a clinical-stage biopharmaceutical company focused on infectious disease, today announced that five abstracts, including one late-breaker, ...

Hewlett Packard Enterprise today announced that global pharma major Lupin Limited (Lupin) headquartered in Mumbai, India, has selected HPE Private Cloud Enterprise for a fully managed turnkey solution ...

Accenture has acquired TalentSprint, a leader in deep tech education, from NSE Academy Ltd., (a wholly owned subsidiary of National Stock Exchange of India Limited (NSE)). TalentSprint offers ...

The Hematology/Oncology Pharmacy Association (HOPA) officially welcomed Robert Mancini, PharmD, BCOP, FHOPA, as its new President during the HOPA Annual Conference in Portland, Oregon on April 11, ...

The pulmonary sarcoidosis treatment landscape is poised for substantial transformation in the coming years, with the 7MM market expected to witness considerable growth by 2032. This expansion is ...

Xlife Sciences says that Veraxa Biotech is to list as a public company on the Nasdaq Global Market through a strategic merger ...

A new report highlights disparities in access to CAR T-cell therapies across Europe, with eligible patient treatment rates as ...